This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Immunic Ag. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Manfred Groppel: Innovator in Autoimmune Disease Treatment
Introduction
Manfred Groppel is a notable inventor based in Munich, Germany. He has made significant contributions to the field of medicine, particularly in the treatment of autoimmune diseases and chronic inflammation. His innovative work has led to the development of a patent that addresses critical health issues.
Latest Patents
Manfred Groppel holds a patent for "IL-17 and IFN-gamma inhibition for the treatment of autoimmune diseases and chronic inflammation." This invention relates to compounds of a specific general formula, including pharmaceutically acceptable salts and solvates. The compounds are designed to inhibit IL-17 and IFN-gamma, which are crucial in the pathogenesis of autoimmune diseases. The patent outlines various structural components that make these compounds suitable for therapeutic applications.
Career Highlights
Throughout his career, Manfred Groppel has been associated with Immunic AG, a company focused on developing innovative therapies for autoimmune diseases. His work has been instrumental in advancing the understanding and treatment of chronic inflammatory conditions.
Collaborations
Manfred has collaborated with notable colleagues such as Jakob Felding and Hella Kohlhof, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
In summary, Manfred Groppel is a distinguished inventor whose work in the field of autoimmune disease treatment has led to valuable patents and collaborations. His contributions continue to impact the medical community positively.